Robert Kirk, PA

NPI: 1689672230
Total Payments
$839.29
2024 Payments
$359.89
Companies
18
Transactions
39
Medicare Patients
258
Medicare Billing
$16,235

Payment Breakdown by Category

Food & Beverage$812.29 (96.8%)
Other$27.00 (3.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $812.29 38 96.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27.00 1 3.2%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $334.15 15 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $79.18 4 $0 (2024)
AstraZeneca Pharmaceuticals LP $54.58 2 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $47.28 2 $0 (2024)
Mallinckrodt Hospital Products Inc. $38.62 2 $0 (2024)
Janssen Pharmaceuticals, Inc $31.86 2 $0 (2024)
Regeneron Healthcare Solutions, Inc. $28.78 1 $0 (2024)
Abbott Laboratories $28.41 1 $0 (2023)
Becton, Dickinson and Company $27.00 1 $0 (2024)
PFIZER INC. $23.81 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $359.89 17 ABBVIE INC. ($89.44)
2023 $459.93 21 ABBVIE INC. ($244.71)
2021 $19.47 1 CooperSurgical, Inc. ($19.47)

All Payment Transactions

39 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/15/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $22.34 General
Category: PSYCHIATRY
08/28/2024 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $17.65 General
Category: Neuroscience
07/20/2024 Becton, Dickinson and Company Site-Rite (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $27.00 General
Category: Catheter Care and Medication Delivery
05/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $24.23 General
Category: DIABETES
05/07/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $15.16 General
Category: Electromedical and Electrotherapeutic Apparatus
04/26/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $17.44 General
Category: Respiratory
04/19/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $28.78 General
Category: INFLAMMATION AND IMMUNOLOGY
04/10/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $19.97 General
Category: HFCWO
03/30/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $21.74 General
Category: ANTI-INFECTIVE
03/26/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $15.55 General
Category: Cardiology
03/18/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $20.66 General
Category: Electromedical and Electrotherapeutic Apparatus
03/01/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $22.81 General
Category: ANTI-INFECTIVE
02/07/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $18.84 General
Category: CRITICAL CARE
02/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $23.05 General
Category: DIABETES
01/19/2024 ABBVIE INC. TEFLARO (Drug), AVYCAZ, DALVANCE Food and Beverage In-kind items and services $19.44 General
Category: ANTI-INFECTIVE
01/17/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $19.78 General
Category: CRITICAL CARE
01/12/2024 ABBVIE INC. DALVANCE (Drug), TEFLARO Food and Beverage In-kind items and services $25.45 General
Category: ANTI-INFECTIVE
12/15/2023 ABBVIE INC. TEFLARO (Drug), DALVANCE, AVYCAZ Food and Beverage In-kind items and services $20.59 General
Category: ANTI-INFECTIVE
12/07/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.21 General
Category: Cardiovascular & Metabolism
11/16/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $18.97 General
Category: Inhibitor of SGLT2 and SGLT1
11/10/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $29.22 General
Category: Rare Disease
11/10/2023 ABBVIE INC. DALVANCE (Drug), TEFLARO Food and Beverage In-kind items and services $25.70 General
Category: ANTI-INFECTIVE
09/29/2023 ABBVIE INC. TEFLARO (Drug) Food and Beverage In-kind items and services $20.08 General
Category: ANTI-INFECTIVE
08/24/2023 ABBVIE INC. TEFLARO (Drug) Food and Beverage In-kind items and services $24.09 General
Category: ANTI-INFECTIVE
08/23/2023 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $15.00 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 5 169 170 $35,762 $9,958
2021 5 89 89 $18,834 $6,277
Total Patients
258
Total Services
259
Medicare Billing
$16,235
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 82 83 $18,026 $5,118 28.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 29 29 $9,030 $2,634 29.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 32 32 $6,936 $1,962 28.3%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 11 11 $1,625 $211.31 13.0%
81003 Automated urinalysis test Office 2022 15 15 $145.00 $33.32 23.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 30 30 $6,210 $2,255 36.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 14 14 $4,200 $1,515 36.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 12 12 $2,484 $1,123 45.2%
99219 Hospital observation care, typically 50 minutes Facility 2021 11 11 $2,750 $979.66 35.6%
99211 Established patient outpatient visit, minimal presenting problem Office 2021 22 22 $3,190 $403.83 12.7%

About Robert Kirk, PA

Robert Kirk, PA is a Medical healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689672230.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Kirk, PA has received a total of $839.29 in payments from pharmaceutical and medical device companies, with $359.89 received in 2024. These payments were reported across 39 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($812.29).

As a Medicare-enrolled provider, Kirk has provided services to 258 Medicare beneficiaries, totaling 259 services with total Medicare billing of $16,235. Data is available for 2 years (2021–2022), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Location Syracuse, NY
  • Active Since 07/08/2005
  • Last Updated 09/11/2018
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1689672230

Products in Payments

  • TEFLARO (Drug) $243.24
  • LifeVest (Device) $79.18
  • ANDEXXA (Biological) $54.58
  • DALVANCE (Drug) $51.15
  • JARDIANCE (Drug) $47.28
  • AVYCAZ (Drug) $39.76
  • TERLIVAZ (Drug) $38.62
  • DUPIXENT (Biological) $28.78
  • CARDIOMEMS (Device) $28.41
  • Site-Rite (Device) $27.00
  • ELIQUIS (Drug) $23.81
  • ABILIFY ASIMTUFII (Drug) $22.34
  • SMARTVEST (Device) $19.97
  • Uterine Manipulators & Injectors (Device) $19.47
  • Inpefa (Drug) $18.97
  • INVEGA (Drug) $17.65
  • Arikayce (Drug) $17.44
  • BIOFIRE BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL (Device) $16.88
  • Repatha (Biological) $15.55
  • VERQUVO (Drug) $15.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Syracuse